tradmap

GRDN Financials Guardian Pharmacy Services, Inc.

2 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →

Growth & profitability

  • Revenue has grown 17.9% per year over the past 1 years.
  • Operating margin has expanded, at 5.0% in the latest year.
  • Free cash flow has grown 100.8% per year over the past 1 years.

Financial health

  • The company holds more cash ($66M) than total debt ($0).
  • Operating income covered interest expense 109× in the latest year, up from -19.2× 1 years ago.
Revenue & net income
-$110M $669M $1B $0 2024 2025
RevenueNet income
Margins (gross / operating / net)
-9% 6% 20% 0% 2024 2025
GrossOperatingNet
Free cash flow (CFO − capex)
$0 $43M $87M 2024 2025
Free cash flow
Cash vs total debt
$0 $33M $66M 2024 2025
CashTotal debt
Cash flow: operating / investing / financing
-$32M $34M $100M $0 2024 2025
OperatingInvestingFinancing

Key annual figures

FYRevenueNet incomeGross MOp MFCFTotal debtCash
2025 $1.4B $49M 20.2% 5.0% $87M $0 $66M
2024 $1.2B -$110M 19.9% -5.1% $43M $0 $5M

Frequently asked questions

Is GRDN growing its revenue and profit?

Over the past 1 years, Guardian Pharmacy Services, Inc.'s revenue has grown 17.9% per year. These are computed facts, not advice.

How much debt does GRDN have?

As of FY2025, Guardian Pharmacy Services, Inc. reported $0 of total debt against $66M of cash; operating income covered interest expense 109×.

What is GRDN's profit margin?

In FY2025, gross margin was 20.2%, operating margin 5.0%, and net margin 3.4%.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.